Canadian Pharmacists Journal

所有列名作者必须满足以下标准：对研究的概念、设计、数据获取、分析或解释做出重要贡献；起草文章或对其进行重要的学术内容修改；批准文章的最终发表版本；同意对工作的所有方面负责并解决与其准确性或完整性相关的任何问题。 模型中文摘要

All listed authors must meet the following criteria: Made a significant contribution to the concept, design, acquisition, analysis or interpretation of data Drafted the article or revised it critically for important intellectual content Approved the final version of the article for publication Agreed to be accountable for all aspects of the work and resolved any issues related to its accuracy or i…

期刊致力于促进研究的开放、透明和可重复性，鼓励作者在适当的伦理和法律考虑下：在相关的公共数据存储库中共享研究数据；包含链接到数据的数据可用性声明；如果无法共享数据，使用声明确认原因；在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

请在此标题下包含伦理批准声明，即使您已在方法部分包含伦理批准信息。如果不需要伦理批准，您需要明确说明。所有报告涉及人类参与者、人类数据或人体组织的研究的论文必须声明相关伦理委员会或机构审查委员会批准了研究，或豁免了批准要求，提供审查委员会的全名和机构以及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. If you wish to have color figures in the printed version, the following fees apply: The first color image is $800, and it is $200 for any additional color images within the same contribution. Optional open access publishing is availa…

以下摘要描述了本期刊的同行评审流程：身份透明度：单盲评审；评审者与编辑互动；评审信息不公开。您的稿件将进行初步评估。如果不符合这些指南中规定的要求，将在同行评审之前退回给您进行修改。如果超出期刊范围或其他不合适，稿件可能会在此时被直接拒稿而无需同行评审。通过初步评估后，您的稿件将进行同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题。请阅读Sage关于抄袭的完整政策以及我们可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

期刊将考虑已在预印本服务器上发布的稿件。请在提交稿件时在指定字段中输入预印本DOI。我们建议您在提交时告知期刊编辑部您已发布的预印本。请注意，在稿件接受同行评审期间，您不应在预印本服务器上发布稿件的更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

期刊遵循ICMJE要求，临床试验必须在WHO批准的公共试验注册处注册，注册时间不晚于首例参与者入组时，作为考虑发表的条件。试验注册处名称和URL以及注册号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.